The EyeBOX is as powerful as it is easy to use. In under 4 minutes, Oculogica’s proprietary technology collects and analyzes over 100,000 data points across 67-domains of eye movement to generate an objective assessment of concussion that is unique to each patient. 2020 Fast Company Most Creative Companies.
Detailed, real-time information on TBI and concussion facilitates rapid and precise diagnosis and improved patient outcomes. The EyeBOX requires no baseline data nor individual calibration, and therefore results cannot be influenced by patient will.
Baseline-free
Proprietary EyeBOX technology generates quick and accurate analysis without the need for pre-incident patient data.
Objective
67-point analysis enables greater diagnostic precision and improved patient outcomes. Unlike current standards of care, the EyeBOX goes beyond symptoms to measure brain function.
Easy to Use
Simple, calibration-free testing requires no literacy, language fluency or the ability to follow special directions. Accurate evaluation can be achieved in pre-verbal and verbally impaired patients.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2013
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was OCULOGICA founded?
OCULOGICA was founded in 2013.
What industry is OCULOGICA in?
OCULOGICA operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is OCULOGICA based?
OCULOGICA is headquartered in New York, United States.
Find investors for your startup like OCULOGICA
Gritt sends AI-personalised outreach to each investor — from your Gmail
